Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Puumala virus (PUUV) Gn-Gc glycoprotein complex, consisting of the Gn and Gc glycoproteins, is essential for viral entry into host cells. Gn mediates attachment to host cell receptors, while Gc facilitates membrane fusion upon endocytosis and exposure to low pH. The Gn-Gc complex is a major target for neutralizing antibodies and a key determinant of PUUV pathogenicity. Targeting these glycoproteins is a viable strategy for antiviral development.
Inhibition of viral entry by blocking attachment (Gn) or fusion (Gc)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Puumala Virus Glycoprotein Gn-Gc (Gn-Gc).